Capstone Investment Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,900	Closed	-$952K	–	1078
2024 Q1	$952K	Hold	10,900	–	–	﹤0.01%	558
2023 Q4	$1.05M	Hold	10,900	–	–	﹤0.01%	332
2023 Q3	$964K	Hold	10,900	–	–	﹤0.01%	406
2023 Q2	$945K	Sell	10,900 -29	-0.3%	-$2.51K	﹤0.01%	319
2023 Q1	$1.06M	Buy	10,929 +29	+0.3%	+$2.82K	0.01%	262
2022 Q4	$1.13M	Hold	10,900	–	–	0.01%	360
2022 Q3	$924K	Hold	10,900	–	–	0.01%	485
2022 Q2	$903K	Buy	10,900 +8,212	+306%	+$680K	﹤0.01%	447
2022 Q1	$207K	Buy	+2,688	New	+$207K	﹤0.01%	647
2021 Q3	–	Hold	0	–	–	–	937
2021 Q2	–	Sell	-12,000	Closed	-$906K	–	709
2021 Q1	$906K	Sell	12,000 -4,235	-26%	-$320K	﹤0.01%	266
2020 Q4	$1.42M	Buy	16,235 +1,831	+13%	+$161K	﹤0.01%	196
2020 Q3	$1.1M	Sell	14,404 -8,742	-38%	-$665K	0.01%	188
2020 Q2	$2.86M	Sell	23,146 -4,854	-17%	-$599K	0.02%	98
2020 Q1	$2.37M	Sell	28,000 -500	-2%	-$42.3K	0.04%	107
2019 Q4	$2.41M	Buy	28,500 +6,000	+27%	+$507K	0.01%	168
2019 Q3	$1.52M	Sell	22,500 -9,500	-30%	-$641K	0.01%	152
2019 Q2	$2.74M	Sell	32,000 -2,000	-6%	-$171K	0.02%	138
2019 Q1	$3.02M	Sell	34,000 -1,000	-3%	-$88.8K	0.03%	99
2018 Q4	$2.98M	Buy	+35,000	New	+$2.98M	0.04%	103
2018 Q2	–	Sell	-6,500	Closed	-$527K	–	326
2018 Q1	$527K	Buy	+6,500	New	+$527K	0.01%	164
2017 Q4	–	Sell	-14,200	Closed	-$1.32M	–	406
2017 Q3	$1.32M	Buy	+14,200	New	+$1.32M	0.05%	120
2016 Q1	–	Sell	-5,242	Closed	-$549K	–	578
2015 Q4	$549K	Sell	5,242 -2,799	-35%	-$293K	0.01%	238
2015 Q3	$846K	Buy	+8,041	New	+$846K	0.02%	123
2015 Q2	–	Sell	-18,500	Closed	-$2.31M	–	149
2015 Q1	$2.31M	Buy	+18,500	New	+$2.31M	0.04%	96